0 Bedömningar
ID

4503

Beskrivning

ACNS1123 Eligibility Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Länk

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Nyckelord

Versioner (2)
  1. 2013-12-09 2013-12-09 - Martin Dugas
  2. 2015-06-02 2015-06-02 -
Uppladdad den

9 december 2013

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0 Legacy
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    ACNS1123 Eligibility - 3377519v1.0

    Engelsk

    No Instruction available.

    1 Formulär  
    1. StudyEvent: SE.0000
      1. No Instruction available.
    Stratification
    Beskrivning

    Stratification

    ACNS1123 Stratum
    Beskrivning

    ClinicalStudyACNS1123StratificationFactorsType

    Datatyp

    text

    Study Treatment
    Beskrivning

    TreatmentAssignmentType

    Datatyp

    text

    Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
    Beskrivning

    TreatmentBeginDate

    Datatyp

    date

    Elig - Block 1
    Beskrivning

    Elig - Block 1

    Is the patient enrolled on the ALTE07C1 study?
    Beskrivning

    OtherStudyEnrollmentInd-2

    Datatyp

    text

    Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
    Beskrivning

    PatientAgeEligibilityDeterminationInd-2

    Datatyp

    text

    Was definitive diagnostic surgery performed?
    Beskrivning

    FirstDiagnosisFromSurgicalProcedureIndicator

    Datatyp

    text

    Date of definitive diagnostic surgery or clinical diagnosis:
    Beskrivning

    PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate

    Datatyp

    date

    Was lumbar CSF cytology obtained?
    Beskrivning

    CerebrospinalFluidCellInd-3

    Datatyp

    text

    Was it medically contraindicated? (If no,)
    Beskrivning

    CerebrospinalFluidDiagnosticProcedureCytologyContraindicatedInd-2

    Datatyp

    text

    Was lumbar CSF cytology negative?
    Beskrivning

    LaboratoryProcedureLumbarPunctureCerebrospinalFluidNegativeFindingOutcomeInd-2

    Datatyp

    text

    Elig - Block 2
    Beskrivning

    Elig - Block 2

    Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
    Beskrivning

    GermCellTumorHistologicClassificationDiagnosisInd-2

    Datatyp

    text

    Elig - Block 3
    Beskrivning

    Elig - Block 3

    Does patient have newly diagnosed localized primary CNS NGGCT?
    Beskrivning

    NewPrimaryMalignantNeoplasmCentralNervousSystemGermCellTumorDiagnosisInd-2

    Datatyp

    text

    Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
    Beskrivning

    PathologyFindingsIndicator

    Datatyp

    text

    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    Beskrivning

    PatientProtocolRequirementEligibilityDeterminationInd-2

    Datatyp

    text

    Elig - Block 4
    Beskrivning

    Elig - Block 4

    Does patient have newly diagnosed localized primary CNS germinoma?
    Beskrivning

    NewChildhoodBrainGerminomaDiagnosisInd-2

    Datatyp

    text

    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    Beskrivning

    PatientProtocolRequirementEligibilityDeterminationInd-2

    Datatyp

    text

    Elig - Block 5
    Beskrivning

    Elig - Block 5

    Peripheral absolute neutrophil count (ANC) (number/uL)
    Beskrivning

    LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue

    Datatyp

    double

    Måttenheter
    • ul
    ul
    Platelet count (number/uL): (Transfusion Independent)
    Beskrivning

    LaboratoryProcedurePlateletResultSpecifiedValue

    Datatyp

    double

    Måttenheter
    • 1000/uL
    1000/uL
    Hemoglobin(g/dL) (May receive RBC transfusion)
    Beskrivning

    LaboratoryProcedureHemoglobinResultSpecifiedValue

    Datatyp

    double

    Måttenheter
    • g/dL
    g/dL
    Elig - Block 5
    Beskrivning

    Elig - Block 5

    Creatinine clearance (mL/min/1.73m²):
    Beskrivning

    LaboratoryProcedureCreatinineClearanceOutcomeValue

    Datatyp

    double

    Radioisotope GFR(mL/min/1.73 m²)
    Beskrivning

    LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue

    Datatyp

    double

    Måttenheter
    • mL/Min/1.73m2
    mL/Min/1.73m2
    Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
    Beskrivning

    LaboratoryProcedureCreatinineResultSpecifiedValue

    Datatyp

    double

    Måttenheter
    • mg/dL
    mg/dL
    Elig - Block 7
    Beskrivning

    Elig - Block 7

    Total bilirubin (mg/dl), ULN
    Beskrivning

    LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue

    Datatyp

    double

    Måttenheter
    • mg/dL
    mg/dL
    Total bilirubin Value (mg/dl):
    Beskrivning

    LaboratoryProcedureTotalBilirubinResultValue

    Datatyp

    double

    Måttenheter
    • mg/dL
    mg/dL
    SGPT (ALT) or SGOT (AST) U/L, ULN:
    Beskrivning

    LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue

    Datatyp

    double

    SGPT (ALT) or SGOT (AST), U/L
    Beskrivning

    LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue

    Datatyp

    double

    Elig - Block 8
    Beskrivning

    Elig - Block 8

    Does patient have seizure disorder?
    Beskrivning

    PatientSeizureDiseaseorDisorderInd-3

    Datatyp

    text

    Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
    Beskrivning

    NeurologicalEvaluationSeizureSymptomInd-2

    Datatyp

    text

    Is patient in status, coma or assisted ventilation at study entry?
    Beskrivning

    PatientMechanicalVentilationUseInd-2

    Datatyp

    text

    Elig - Block 9
    Beskrivning

    Elig - Block 9

    Does patient have mature teratoma with normal tumor markers?
    Beskrivning

    PatientCentralNervousSystemGermCellTumorDiagnosisInd-2

    Datatyp

    text

    Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
    Beskrivning

    ExternalBrainVentricleCentralNervousSystemGermCellTumorDiagnosisInd-2

    Datatyp

    text

    Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
    Beskrivning

    MetastaticDiseaseorDisorderMagneticResonanceImagingCerebrospinalFluidDiagnosisInd-2

    Datatyp

    text

    Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
    Beskrivning

    SurgicalInterventionCorticosteroidAdministeredInd-2

    Datatyp

    text

    Is patient post menarcheal?
    Beskrivning

    PediatricEndocrineMensesOnsetInd-2

    Datatyp

    text

    Was a pregnancy test performed?
    Beskrivning

    PatientPregnancyTestIndicator

    Datatyp

    text

    Is patient pregnant? (If yes above,)
    Beskrivning

    PatientPregnancyInd-2

    Datatyp

    text

    Is patient nursing?
    Beskrivning

    PersonBreastFeedingExclusionCriteriaIndicator

    Datatyp

    text

    Has patient agreed to stop breastfeeding? (If yes above,)
    Beskrivning

    BreastFeedingStopAgreementInd-4

    Datatyp

    text

    Has patient agreed to use an effective contraceptive method for the duration of the study participation?
    Beskrivning

    ContraceptionAgreementInd

    Datatyp

    text

    Elig - Block 10
    Beskrivning

    Elig - Block 10

    Date Informed Consent Signed
    Beskrivning

    InformedConsentFormSignedDate

    Datatyp

    date

    Have all institutional, FDA, and NCI requirements for human studies been met?
    Beskrivning

    StudyCompleteRequirementsInd-2

    Datatyp

    text

    Comments
    Beskrivning

    ResearchCommentsText

    Datatyp

    text

    Tillbaka till toppen

    Similar models

    No Instruction available.

    1 Formulär
    1. StudyEvent: SE.0000
      1. No Instruction available.
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Stratification
    CL.1
    Code List
    ACNS1123 Stratum
    CL Item
    Stratum 1 - Nggct (Stratum 1 - NGGCT)
    CL Item
    Stratum 2 - Germinoma (Stratum 2 - Germinoma)
    Item
    Study Treatment
    text
    CL.2
    Code List
    Study Treatment
    CL Item
    Treatment 1: A,b,a,b,a,b (Treatment 1 A B A B A B)
    CL Item
    Treatment 2: A,a,a,a (Treatment 2 A A A A)
    TreatmentBeginDate
    Item
    Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
    date
    Item Group
    Elig - Block 1
    Item
    Is the patient enrolled on the ALTE07C1 study?
    text
    CL.3
    Code List
    Is the patient enrolled on the ALTE07C1 study?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
    text
    CL.4
    Code List
    Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Was definitive diagnostic surgery performed?
    text
    CL.5
    Code List
    Was definitive diagnostic surgery performed?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate
    Item
    Date of definitive diagnostic surgery or clinical diagnosis:
    date
    Item
    Was lumbar CSF cytology obtained?
    text
    CL.6
    Code List
    Was lumbar CSF cytology obtained?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Was it medically contraindicated? (If no,)
    text
    CL.7
    Code List
    Was it medically contraindicated? (If no,)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL.8
    Code List
    Was lumbar CSF cytology negative?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item Group
    Elig - Block 2
    Item
    Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
    text
    CL.9
    Code List
    Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item Group
    Elig - Block 3
    Item
    Does patient have newly diagnosed localized primary CNS NGGCT?
    text
    CL.10
    Code List
    Does patient have newly diagnosed localized primary CNS NGGCT?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
    text
    CL.11
    Code List
    Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
    CL Item
    Yes (YES)
    CL Item
    No (NO)
    Item
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    text
    CL.14
    Code List
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have newly diagnosed localized primary CNS germinoma?
    text
    CL.13
    Code List
    Does patient have newly diagnosed localized primary CNS germinoma?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    text
    CL.14
    Code List
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue
    Item
    Peripheral absolute neutrophil count (ANC) (number/uL)
    double
    LaboratoryProcedurePlateletResultSpecifiedValue
    Item
    Platelet count (number/uL): (Transfusion Independent)
    double
    LaboratoryProcedureHemoglobinResultSpecifiedValue
    Item
    Hemoglobin(g/dL) (May receive RBC transfusion)
    double
    LaboratoryProcedureCreatinineClearanceOutcomeValue
    Item
    Creatinine clearance (mL/min/1.73m²):
    double
    LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue
    Item
    Radioisotope GFR(mL/min/1.73 m²)
    double
    LaboratoryProcedureCreatinineResultSpecifiedValue
    Item
    Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
    double
    LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue
    Item
    Total bilirubin (mg/dl), ULN
    double
    LaboratoryProcedureTotalBilirubinResultValue
    Item
    Total bilirubin Value (mg/dl):
    double
    LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue
    Item
    SGPT (ALT) or SGOT (AST) U/L, ULN:
    double
    LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue
    Item
    SGPT (ALT) or SGOT (AST), U/L
    double
    Item Group
    Elig - Block 8
    Item
    Does patient have seizure disorder?
    text
    CL.15
    Code List
    Does patient have seizure disorder?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
    text
    CL.16
    Code List
    Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient in status, coma or assisted ventilation at study entry?
    text
    CL.17
    Code List
    Is patient in status, coma or assisted ventilation at study entry?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item Group
    Elig - Block 9
    Item
    Does patient have mature teratoma with normal tumor markers?
    text
    CL.18
    Code List
    Does patient have mature teratoma with normal tumor markers?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
    text
    CL.19
    Code List
    Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
    text
    CL.20
    Code List
    Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
    text
    CL.21
    Code List
    Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient post menarcheal?
    text
    CL.22
    Code List
    Is patient post menarcheal?
    CL Item
    Yes (yes)
    CL Item
    No (no)
    Item
    Was a pregnancy test performed?
    text
    CL.23
    Code List
    Was a pregnancy test performed?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient pregnant? (If yes above,)
    text
    CL.24
    Code List
    Is patient pregnant? (If yes above,)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL.25
    Code List
    Is patient nursing?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Has patient agreed to stop breastfeeding? (If yes above,)
    text
    CL.26
    Code List
    Has patient agreed to stop breastfeeding? (If yes above,)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Has patient agreed to use an effective contraceptive method for the duration of the study participation?
    text
    CL.27
    Code List
    Has patient agreed to use an effective contraceptive method for the duration of the study participation?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL Item
    N/a, Patient Is Not Of Reproductive Potential (NA patient is not of reproductive potential)
    Item Group
    Elig - Block 10
    InformedConsentFormSignedDate
    Item
    Date Informed Consent Signed
    date
    Item
    Have all institutional, FDA, and NCI requirements for human studies been met?
    text
    CL.28
    Code List
    Have all institutional, FDA, and NCI requirements for human studies been met?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    ResearchCommentsText
    Item
    Comments
    text
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial